Natural killer T cells express a conserved, semi-invariant ab T cell receptor that has specificity for self glycosphingolipids and microbial cell wall a-glycuronosylceramide antigens presented by CD1d molecules. Here we report the crystal structure of CD1d in complex with a short-chain synthetic variant of a-galactosylceramide at a resolution of 2.2 Å . This structure elucidates the basis for the high specificity of these microbial ligands and explains the restriction of the a-linkage as a unique pathogenspecific pattern-recognition motif. Comparison of the binding of altered lipid ligands to CD1d and T cell receptors suggested that the differential T helper type 1-like and T helper type 2-like properties of natural killer T cells may originate largely from differences in their 'loading' in different cell types and hence in their tissue distribution in vivo.
Natural killer T (NKT) cells are a conserved lymphocyte lineage expressing a semi-invariant T cell receptor (TCR) with variable (V) and joining (J) regions V a 14-J a 18-V b 8, V a 14-J a 18-V b 7 or V a 14-J a 18-V b 2 in mouse and V a 24-J a 18-V b 11 in human. They are important in regulating a variety of microbial, allergic, autoimmune and tumor conditions through the rapid and substantial secretion of T helper type 1 (T H 1) and T H 2 cytokines and chemokines 1 . Unlike other T cells, NKT cells are restricted to a non-major histocompatibility complex (MHC) molecule, CD1d, which binds lipids and glycolipids instead of peptides. Whereas other CD1 isotypes in humans can present a large variety of bacterial compounds that stimulate individual T cell clones expressing diverse TCRs 2 , CD1d seems to have specialized in the presentation of a limited set of lipids for recognition by the entire NKT cell population or a large fraction thereof. Two main classes of agonist ligands of mouse and human NKT cells have been identified: a self glycosphingolipid, isoglobotrihexosylceramide 3 ; and a family of a-glycuronosylceramides (a-galacturonosyl and a-glucuronosylceramide) that substitute for lipopolysaccharide in the cell walls of some Gram-negative lipopolysaccharide-negative bacteria, including sphingomonas [4] [5] [6] . Although isoglobotrihexosylceramide seems to be the only required ligand for NKT cell development, the dual specificity for self and foreign ligands, a general feature of many innate-like lymphocyte subsets 7 , underlies the recruitment and activation of NKT cells in various disease conditions, including microbial infections 5 . Another microbial ligand present in the cell wall of mycobacteria, phosphatidylinositol mannoside, also seems to be a natural ligand of NKT cells 8 .
Microbial a-glycuronosylceramides are of particular interest because of their relevance in the context of infection in vivo and their very close structural homology with a highly potent agonist of human and mouse NKT cells, a-galactosylceramide (a-GalCer) 9 , which was isolated from marine sponges. These molecules are both a-stereoisomers, a stereochemistry absent from mammalian glycosphingolipids, and are phyto-ceramides because of the additional hydroxyl group at the C 4 position of sphingosine that is found in a limited fraction of mammalian glycolipids 10 .
Activation of NKT cells by these agonist ligands in vivo is initiated by CD1d-expressing antigen-presenting cells, including dendritic cells, macrophages and B cells, and results in immediate reciprocal activation of the antigen-presenting cell, through CD40 ligand-CD40 interaction, and NK cells 11 . These early events and the massive release of T H 1 and T H 2 cytokines and chemokines by activated NKT cells underlie the powerful adjuvant properties of these agonists for CD4 + , CD8 + T cell and B cell immunity 11, 12 . NKT cells therefore seem to constitute the main Toll-like receptor-independent pathway leading to full dendritic cell maturation and immunity.
Because ligation of NKT cells induces both T H 1 and T H 2 cytokines and NKT cells are essential in regulating a variety of T H 1-and T H 2-mediated immune responses, much attention has been focused on the development of variants of NKT cell agonists with biased T H 1 or T H 2 properties. All the T H 2 variants reported so far have been based on changes in the lipid rather than on the carbohydrate moieties of the glycolipid [13] [14] [15] . One variant called OCH, produced by truncation of the sphingosine moiety of a-GalCer to only nine carbons, induces more interleukin-4 (IL-4) secretion and less interferon-g secretion both in vitro and in vivo and can prevent experimental autoimmune encephalitis in mice 13 . This observation has been extended to other variants with either short fatty acid or sphingosine chains 14 .
Here we report the crystal structure of the complex between CD1d and one of these variant agonist ligands, which provides unique insights into the biology of innate lipid recognition by NKT cells and the molecular mechanism of NKT cell activation by a-GalCer and its variants. Furthermore, the combination of the structural comparisons and modeling of a series of ligands for V a 14 TCRs with pharmacological studies in vivo strongly suggest that the functional differences demonstrated by the short lipid variants may be more related to differential uptake and presentation by CD1d-expressing antigenpresenting cells than to intrinsic differences in TCR recognition.
RESULTS

PBS-25 is a strong NKT cell agonist
To probe the biological properties of a-GalCer and a-glucuronosylceramide, we systematically changed the lengths of the sphingosine and fatty acid chains, the unsaturation of the acyl chain, the stereochemistry of the head group and the derivatization of the sugar 14 . The most notable series of compounds was obtained by shortening the length of either alkyl chain. One of these compounds, PBS-25, had an eight-carbon (C 8 ) acyl chain instead of the long C 26 fatty acid chain of the original a-GalCer. Otherwise, the phyto-sphingosine and a-galactose moieties of PBS-25 were similar to their counterparts in a-GalCer. We tested this synthetic compound in vitro for its ability to stimulate the canonical V a 14-bearing NKT hybridoma DN32.D3 along with a-GalCer and OCH (called PBS-20 in our experiments). When 'loaded' onto plate-bound CD1d, PBS-25 was as potent as a-GalCer and was slightly more potent than OCH in stimulating mouse DNDN32.D3 T cells (Fig. 1a) . We obtained similar results for a human NKT cell line (data not shown). CD1d tetramers loaded with either a-GalCer or PBS-25 also showed similar staining profiles when tested on V a 14 NKT hybridomas, mouse NKT cells (blood, spleen and liver) and a human NKT cell line (Fig. 1b and data not shown) . Thus, like a-GalCer, PBS-25 can be loaded onto mouse and human CD1d and can bind the whole population of canonical V a 14 or V a 24 NKT cells. Notably, like all other variants of a-GalCer with shorter fatty acid chains, PBS-25 had an accentuated T H 2 profile compared with that of a-GalCer 14 .
PBS-25 solubility and loading properties
To further characterize this compound, we assessed its biophysical properties and binding characteristics. Unlike a-GalCer or OCH, which are poorly soluble and require either detergent and/or sonication for solubilization, PBS-25 is readily soluble in aqueous solutions. This physical property translated to efficient loading of PBS-25 onto CD1d, as measured by isoelectric focusing (Fig. 2a) . This difference between PBS-25 and a-GalCer was best illustrated in an 'on rate' stimulation assay in which plate-immobilized CD1d molecules were loaded with a constant amount of lipid for various times and assayed for loading by T cell activation (Fig. 2b) . Whereas a-GalCer required a full 24 h of incubation to reach suboptimal loading, PBS-25 reached equilibrium in about 60 min. The addition of lipid-transfer proteins, such as mouse saposin or mouse GM2 activator, did not influence the kinetic activity of PBS-25 but did substantially improve the loading of a-GalCer (data not shown).
In the 'off-rate' stimulation assay in which, after loading, CD1d molecules were incubated at 37 1C in buffer containing no lipid before cells were added, PBS-25 acted like a-GalCer, with very long half-lives and no apparent dissociation over the period tested (Fig. 2c) . This long half-life indicates that both lipids have very similar affinities for CD1d and that they differed mainly in their critical micellar concentration. Finally, we also tested CD1d-a-GalCer and CD1d-PBS-25 complexes for thermal denaturation by circular dichroism spectrum measurement. Thermal denaturation curves have been established as a 'faithful' assay for the stability of peptide-MHC complexes 16 . Most lipids conferred identical thermal stability to mouse CD1d molecules (Fig. 2d) . In contrast, PBS-25 shifted the denaturation curve by about 5 1C to higher temperatures, indicating that CD1d-PBS-25 complexes are more stable than CD1d-a-GalCer complexes or endogenous CD1d-lipid mixtures (the so-called 'empty' molecules), despite the substantially decreased length of the acyl chain.
CD1d-PBS-25 affinity for V a 14 TCR The affinity of CD1d-a-GalCer for the semi-invariant V a 14 TCR is in the low nanomolar range (30-90 nM) 17 , which explains the exquisite sensitivity of NKT cells to minute concentrations of a-GalCer and makes NKT cells very efficient sensors for a-GalCer-like bacterial compounds. Surface plasmon resonance measurements of the affinity of CD1d-PBS-25 complexes for recombinant V a 14-V b 8 TCRs yielded similar results, with fast 'on rates' (2.73 Â 10 4 /M per second) and slow 'off rates' (8.53 Â 10 À3 per second) for a dissociation constant of 0.313 mM. This result translated into almost identical staining in the tetramer decay assay for CD1d-a-GalCer and CD1d-PBS-25 tetramers (Fig. 1b) . The solubility of PBS-25 and its biophysical characteristics thus made it a prime candidate for structural studies with CD1d and V a 14 TCRs.
Structure determination of the CD1d-PBS-25 complex
For crystallographic studies, we loaded mouse CD1d molecules with a sixfold (molar) excess of PBS-25 in phosphate-buffered saline for 16 h at 25 1C. We purified monomeric lipid-CD1d complexes by sizeexclusion chromatography, concentrated them to 7.0 mg/ml in 20 mM HEPES buffer, pH 7.5, and crystallized them for high-resolution diffraction data collection. We determined the structure by molecular replacement using mouse CD1d as the starting model 18 and refined it to a resolution of 2.2 Å ( Table 1 and Fig. 3 ) with R cryst and R free values of 24.2% and 29.3%, respectively. In the Ramachandran plot, 90.2% of the residues are in the most-favored region; 9.2% and 0.6% of the residues are in additionally allowed and generously allowed regions, respectively. The asymmetric unit of the crystal contains two CD1-lipid complexes (A and B) that are very similar, as judged by their root-mean-square deviation (r.m.s.d. of 0.31 Å for C a ). Thus, we have described here the CD1d complex structure and ligand interactions for molecule A, unless otherwise indicated.
Interaction of PBS-25 with CD1d
The basic architecture of mouse CD1d has been described 18 . The heterodimer is composed of the three CD1d heavy-chain domains, a1, a2 and a3, which noncovalently associate with b 2 -microglobulin ( Fig. 3a,b) . The a1 and a2 helices lie on top of six b-strands and form a narrow but deep binding groove, which can further be divided into two large hydrophobic pockets, called A¢ and F¢, that merge to form the entry portal for lipid binding.
The short-chain PBS-25 ( Fig. 3c ) is bound to CD1 in a way such that the galactose headgroup is located at the boundary between the A¢ and F¢ pockets, allowing the two alkyl chains to be inserted into each pocket (Figs. 3 and 4). Both alkyl chains are initially inserted perpendicular to the b-sheet platform and then extend more laterally toward the ends of the A¢ and F¢ pockets, respectively (Fig. 3b) . Aromatic residues Tyr73 (A¢ pocket), Phe77 and Trp133 (F¢ pocket) make extensive van der Waals interactions with the glycolipid (Fig. 4a) , stabilizing both alkyl chains after insertion into the individual binding pockets. The phytosphingosine moiety fully occupies the F¢ pocket, which can accommodate linear alkyl chains of up to C 18 . The F¢ pocket is shorter and less deeply buried than the A¢ pocket, which unexpectedly contains the short C 8 fatty acid. The A¢ pocket is the most conserved pocket in all of the CD1 isoforms that have been characterized structurally so far. All A¢ pockets contain a central pole formed by Phe70 and Val12 (CD1a and CD1b) or Cys12 (mouse CD1), which transects the pocket perpendicular to the b-sheet platform. The alkyl chains of each ligand must circle around this pole. More detailed analyses showed that the A¢ pocket of mouse CD1d has more resemblance to CD1b than to CD1a (data not shown; ref. 19) . Whereas the narrow, winding A¢ pocket of CD1a has a well defined terminus, that of CD1d is shaped more like a flat dish, in which the alkyl chain can fully encircle the pole, as in CD1b 20 . As the short-chain fatty acid terminates at the entrance to this A¢ pocket, the structure determined here did not show in which orientation the pole was encircled by a long chain ligand. However, it seems reasonable that the long-chain (C 26 ) fatty acid of the full-length a-GalCer would run counterclockwise, when viewed down into the binding groove, as noted for an endogenous ligand bound to CD1d (data not shown).
Tyr73 makes seven van der Waals contacts with the alkyl chain, thereby 'pulling' it toward the a1 helix, which would favor lipid entry into the A¢ pocket in a counterclockwise orientation. No other obvious structural feature seems to hinder the alkyl chain encircling the pole in a clockwise orientation.
A spacer stabilizes the A¢ pocket In addition to electron density corresponding to the glycolipid ligand, there is a well-defined tube of electron density in the deeply buried region of the A¢ pocket that could not be accounted for by the short C 8 fatty acid (Fig. 4a) . This density suggests the presence of a not-yet characterized, linear hydrophobic compound, which acts as a 'spacer lipid' similar to the detergent molecules initially noted in the CD1b-phosphatidylinositol structure 21 . Such a pocket factor could stabilize the hydrophobic binding pockets in the absence of an antigenic groove-filling ligand, such as full-length a-GalCer (C 44 total carbons, instead of the C 26 used here) for CD1d, or GMM for CD1b 22 . A C 16 fatty acid chain could be built with confidence into the electron density and could be connected to the C 8 fatty acid through two methylene units to recapitulate the C 26 fatty acid of the full-length a-GalCer. The presence of this spacer lipid is also reminiscent of the assortment of endogenous peptides that are found in both MHC class I and MHC class II molecules produced in the fly system in the absence of exogenous ligands 23, 24 . This indicates that all MHC and MHC-like molecules have grooves that must be occupied by endogenous ligands to maintain stability and prevent denaturation.
Otherwise, the electron density of PBS-25 is very well defined for the carbohydrate moiety and the polar region of the ceramide backbone compared with any of the other sphingolipids or lipopeptides bound to CD1a and CD1b molecules 19, 21, 22, 25 . The tail end of the sphingosine (the final three carbons) and the deeply buried spacer lipid are not quite as well ordered (Fig. 4a) as the headgroup or the rest of the alkyl chains (Fig. 4b) . Closer analysis of the binding groove showed that the end of the F¢ pocket is broad enough to accommodate the last three carbons in either a slightly upward or downward orientation (Fig. 4a) . 
Specificity of the lipid-CD1d interaction
Precise hydrogen bonding between the glycolipid ligand and CD1d positions the ligand in an orientation that allows each of the two alkyl chains to be inserted into its respective pocket (Fig. 5) . The 2¢-and 3¢-hydroxyl groups of the galactose headgroup are stabilized by Asp153 (a2 helix) of CD1d and the 3¢-, 4¢-hydroxyl groups of the phytosphingosine form hydrogen bonds to Asp80. Such extensive hydrogen bonding between CD1 and its ligand has not been noted for other CD1 complex structures 19, 21, 22, 25 and probably contributes to the stability, specificity and long half-life of the CD1d-PBS-25 and CD1d-a-GalCer complexes. Furthermore, interaction of the a1 helix (Asp80) with the C 3 -, C 4 -hydroxyl groups of the sphingosine backbone leads to a ligand orientation in which the sphingosine chain can be accommodated only in the F¢ pocket and not in the A¢ pocket, as noted for the sulfatide bound to CD1a 19 . We did not observe any water molecules in the vicinity of the polar headgroup, and therefore they do not seem to be critical in binding of the galactose to CD1. A total of 73 contacts (6 hydrogen bonds and 67 van der Waals) are made between the PBS-25 and CD1d, whereas 28 nonpolar, van der Waals contacts are formed between the protein and the spacer lipid. The total surface area buried in the mouse CD1d binding groove for the a-GalCer antigen, spacer lipid and protein is 1,940 Å 2 , of which 1,150 Å 2 is contributed by the protein; 505 Å 2 , by the glycolipid ligand; and 285 Å 2 , by the spacer lipid. The total volume of the groove is 1,410 Å 3 , slightly less than noted for the 'empty' mouse CD1d binding groove (1,650 Å 3 ; Fig. 6a ). This difference is mostly accounted for by a smaller entrance into the binding groove above the F¢ pocket in the PBS-25-bound CD1d structure (Fig. 6b) . Although the r.m.s.d. between the 'empty' CD1d and the CD1d-PBS-25 structure is only 0.89 Å (for Ca), the a1 and a2 helices are closer above the F¢ pocket in the PBS-25-bound CD1d structure, which has important structural consequences. For example, Asp80 (a1) and Asp153 (a2), which form strong hydrogen bonds with the glycolipid, are positioned 1.3 Å closer to each other and Leu84 (a1) and Leu150 (a2) are situated 1.5 Å closer to each other than in the 'empty' structure (Fig. 6c) . In addition, these slight positional changes are accompanied by a conformational change of the side chain of Leu84, which is now located exactly above the F¢ pocket. These changes result in formation of a closed 'roof' above the F¢ pocket that buries the tail of the sphingosine chain inside the binding groove and prevents access 5 ).
The addition of a sulfate (orange) to b-GalCer results in sulfatide, which is a natural mouse CD1d ligand 59 and could introduce a new hydrogen bond and electrostatic interaction between the sulfate and Arg79. Molecular surfaces are presented with electrostatic potentials (red, electronegative; blue, electropositive; À30 to +30 kT/e; Methods) in a top view (a,b,d) and in a front view (f) or as transparent binding pockets with bound ligands in a side view (a,b, bottom row and e). The a-anomeric galactose sits flatly atop the binding groove, in contrast to its b-anomer, which sticks out away from the groove. Protein residues that are involved in hydrogen bonding or the formation of the roof above the F¢ pocket in b are superscripted, and the A¢ and F¢ pockets are labeled in red. to the CD1 surface (Fig. 6a-c) . This situation is in contrast to the F¢ pockets of the CD1b-GMM 22 and CD1a-sulfatide 19 structures, in which the tails of the respective glycolipids reach the CD1 surface and could therefore also interact directly with the TCR.
CD1 a-GalCer models and mutants
To assess the structural requirements of ligand binding to CD1d and NKT cell stimulation, we further interpreted the results of NKT cell stimulation assays based on CD1d mutants or a-GalCer derivatives 9,26-29 using the crystal structure of CD1d-PBS-25. All of these mutants altered the hydrogen bonding network between CD1d and the ligand ( Table 2) . Also, the weaker reactivity of 4-deoxy a-GalCer and the absence of reactivity of 3,4-dideoxy a-GalCer can be explained by the loss of hydrogen bonding with Asp80 and the subsequent mispositioning of the head group for recognition. The absence of reactivity of a-mannosyl ceramide (mannose is a C 2 -epimer of glucose) can be explained by the loss of the hydrogen bond with Asp153 and the presence of an axial 2¢-hydroxyl group, which could 'clash' with the TCR. Similarly, a-glucuronosylceramide (glucose is the C 4 epimer of galactose) is a weaker agonist of NKT cells than is a-GalCer 9 , because its 4¢-hydroxyl group does not participate in hydrogen bonding with CD1d (Fig. 6d,e) . But, unlike mannose, it will not interfere with TCR recognition because its C 4 -hydroxyl group is in an equatorial position. The a-anomeric form of the galactose is critical for NKT cell recognition, as b-GalCer has shown no stimulatory capability in vitro with purified CD1d-b-GalCer in a plate-bound assay, although some minimal activity has been reported in vivo 9, [30] [31] [32] . Overlay of the b-conformer sulfatide (from the CD1a structure 19 ) with PBS-25 showed structural differences between a-and b-anomers (Fig. 6f) . The b-linkage positions the headgroup in a perpendicular orientation relative to the present structure, a change likely to interfere with the docking of V a 14 TCRs (Fig. 6f) and loss of intimate contact with CD1d.
The relatively straightforward modeling of a-GalCer based on the present PBS-25 structure and the similar binding characteristics between a-GalCer and PBS-25 with respect to CD1d and TCR indicate that gross structural differences are not responsible for the different biological functions noted between the short-chain (C 8 ) and longchain (C 26 ) a-GalCer compounds 14 . However, differential solubility and 'on rates' could also translate into different pharmacological properties of the a-GalCer variants. We tested this hypothesis directly in vivo by injecting a-GalCer and PBS-25 into J a 18-deficient mice (to avoid interference with NKT cells) and purifying B cells, macrophages and dendritic cells from the spleens of these mice for stimulation of DN32.D3 cells (Fig. 7) . Dendritic cells and macrophages presented both PBS-25 and a-GalCer, whereas B cells presented only a-GalCer. Because B cells are by far the most abundant CD1d-expressing antigen-presenting cells, we would argue that these differences are likely to have important consequences in vivo for the observed immunological outcomes of altered a-GalCer variants.
DISCUSSION
NKT cells are critical components of the adjuvant network that primes adaptive immune responses. Understanding of their TCR-binding characteristics, activation and modulation of activation through altered ligands at the molecular level is essential for understanding their complex activity in natural settings and for harnessing these functions in vivo by the rational design of NKT cell ligands optimized for vaccine therapies and for the treatment of various forms of autoimmunity, cancer and allergy. The CD1d-PBS-25 structure provides important clues for elucidating the paradigms of NKT cellmediated regulation. It seems that all variants of a-GalCer will anchor their alkyl chains similarly in both mouse and human CD1d molecules 33 . The sphingosine and acyl chains insert into the binding groove in opposite directions at the A¢ and the F¢ boundary to present the sugar head group for TCR recognition. This mode of binding is opposite to the orientation of the sphingosine and fatty acid chains adopted by sulfatide in human CD1a 19 , but it seems to be required for optimal interaction of the a-linked galactose though hydrogen bonding to Asp153 and for anchoring the phytosphingosine to Asp80 through its two hydroxyl groups.
This particular restriction of the conformation of the head group suggests why b-anomers with only one sugar do not activate NKT cells. However, the 'radical' reorientation of b-anomers through b-linkage to the ceramide also brings up the issue of how b-linked head groups are recognized by V a 14 TCRs. The prototype for a b-linked glycolipid is isoglobotrihexosylceramide, the natural selecting ligand of NKT cells 3 . In this case, one-sugar (b-glucosylceramide (b1-1glucose) or two-sugar (lactosylceramide addition of a b 1-4galactose) variants do not stimulate NKT cells in plate-bound assays with purified CD1-lipid complexes. The third sugar, a galactose, is stimulatory only if branched at the a1-3 position (isoglobotrihexosylceramide), but not at the a1-4 position (globotrihexosylceramide) 3 . This would suggest particular interaction of the final galactose with the TCR or perhaps even CD1d. However, this complex sugar cannot be easily modeled based on our data and will require further structure analysis. Alternatively, the same V a 14 TCR might recognize the two complexes, CD1-a-GalCer and CD1-isoglobotrihexosylceramide, with different docking solutions, but this seems unlikely. However, such forms Figure 7 Pharmacological distribution of a-GalCer and PBS-25. The two a-GalCer variants were injected in vivo, and various antigen-presenting cell subsets were tested for their ability to stimulate DN32.D3 IL-2 production (in triplicate). CD11c + represents highly enriched dendritic cells (more than 98% purity), CD11b + represents highly enriched macrophages (more than 98% purity) and B220 + represents highly purified B cells (more than 98% purity). This experiment was done three independent times. Mutant activity is based on published V a 14 NKT cell stimulation studies with alanine mutants 61 . Only residues critical for NKT cell recognition are presented. NA, not applicable.
of alloreactivity have been noted in MHC class I complexes for variant peptides 34 . The recognition of phosphatidylinositol mannoside 8 is an even more complex issue. The backbone of phosphatidylinositol mannoside is a phospholipid rather than a ceramide. The addition of the phosphoryl group will elongate the neck substantially, with the added flexibility possibly allowing the head group to be positioned to one side. It is, however, not possible at present to accurately model its four mannosyl groups based on the structure presented here. The same conclusions apply to ligands such as GD3 (ref. 35) or lipophosphoglycan 36 that seem to stimulate small subsets of NKT cells.
The presence of a 'spacer' or 'filler' lipid in the A¢ pocket is reminiscent of the collection of peptides found in association with MHC class I and MHC class II molecules produced in the same insect expression system that was used for our study 23, 24 . Unexpectedly, the CD1 complex that binds PBS-25 and retains the spacer lipid is more thermodynamically stable than is CD1-a-GalCer itself. Thus, it could be argued that the additional spacer lipid adds stability by not being continuous with the fatty acid of PBS-25 but by acting independently to stabilize the A¢ pocket. This conclusion could also explain why 'spontaneous' loading of a-GalCer is difficult and requires the assistance of lipid-transfer proteins 37 for extraction of this A¢ pocket stabilizer and why PBS-25, with a shorter chain, does not require this additional step. A 'filler' lipid could also explain the stability of nonlipidic small molecules, such as PPBF 38 . Similarly, the very weak agonist activity of compounds with short acyl chains (two to four carbons in length) 14, 26 could be linked to their inability to sufficiently stabilize the A¢ pocket.
The structure of CD1d-PBS-25 also provides a glimpse into the T cell recognition of this complex. The unique complementaritydetermining region 3 (CDR3) of the a-chain is essential for ligand recognition by NKT cells 39 , whereas CDRb loops are diverse 40 , and unrelated V b chains can be paired with canonical V a to recapitulate CD1-a-GalCer recognition 17 . These features would place the a-chain over the A¢ pocket and the b-chain over the F¢ pocket in an orientation very similar to that of MHC class I-and MHC class II-restricted TCRs 41 . As the A¢ pocket is completely closed on top by a network of hydrogen bonds, CDR1a and CDR2a will 'see' only CD1d and no part of the glycolipid. CDR3a would then be over and contact the tightly embedded galactose, where specific interactions could be envisaged between this loop and the 4¢-and 6¢-hydroxyl (and possibly 3¢-hydroxyl) groups of the sugar, as these atoms are well exposed and less tightly bound to CD1d. However, the hydroxyl group at position 6 can be derivatized without any influence on TCR recognition and is therefore not likely to directly influence binding to the TCR (P.B.S., unpublished data). Galactose would position these two hydroxyl groups (2¢ and 4¢) optimally for recognition, whereas glucose would lose contact with its 4¢-hydroxyl group and mannose would loose both 2¢-and 4¢-hydroxyl group contacts.
This simple recognition scheme would explain the differences in recognition for the three variants. In this topology, V b would be over the F¢ pocket of CD1, where binding of the sphingosine induces closure of the groove over the lipid and a substantial narrowing so that the CDRb loops would not have access to the sphingosine. V b would then bind mainly to CD1d residues, particularly for its CDR1b and CDR2b loops. Thus, overall, most TCR interactions would be with CD1d residues, making the recognition event unusually self-reactive, and would then rely mainly on CDR3a, and perhaps CDR3b, for ligand discrimination. This mode of recognition is simple and advantageous, limiting the need for the scanning, docking and twostep recognition that is required for MHC-restricted TCRs 42 that must recognize and differentiate more diverse sets of bound ligands. In support of this model, studies of CD1d-a-GalCer-V a 14 TCR interactions have demonstrated that the binding is of high affinity and requires no accommodation between the CD1 and TCR surfaces 17 . The 'flip side' of this mode of recognition is the high degree of selfreactivity that arises because of the extensive contacts with CD1d. Perhaps this propensity for self-reactivity underlies TCR recognition of the self ligand isoglobotrihexosylceramide as an agonist and its function as an alternate physiological ligand in disease.
Although a-GalCer and PBS-25 are synthetic ligands of NKT cells that are of pharmacological importance for the manipulation of immunity, their close relationship with microbial cell wall aglycuronosylceramides emphasizes the physiological relevance of our study. In fact, it is possible that the a-GalCer purified from marine sponges based on its antitumor properties 9 originated from bacterial symbionts known to colonize these marine sponges. A similar hypothesis has been proposed for an antitumor polyketide isolated from the marine sponge Theonella swinhoei 43 .
The other important conclusion of our work relates to the T H 2 bioactivity of the short lipid variants of a-GalCer. As demonstrated here, structural differences are unlikely to explain the notable functional properties of these altered ligands. For PBS-25, our combined structural and functional in vivo studies suggest that other differences unrelated to TCR recognition, that is, the cell types that differentially uptake and present these ligands, are also likely to be critical. Similar conclusions about the pharmacology and in vivo processing of a-GalCer derivatives have been reached before 15, 44 . Differential solubility, access to lipid transfer proteins and receptor-mediated uptake could be involved. Indeed, it has been suggested that differences in the presentation of short and long variants of mycolic acids are due to differential access to endosomal compartments 45 . The di-unsaturated C20:2 fatty acid a-GalCer, which also elicits strong T H 2 responses both in vitro and in vivo, also seems to have a unique pharmacology 15 . It will be necessary to test this hypothesis systematically for compounds such as OCH that deviate from the classical a-GalCer activity.
In conclusion, we have reported here the structure of the prototype CD1-a-glycosylceramide complex that physiologically activates human and mouse NKT cell populations in the context of infection by Gramnegative lipopolysaccharide-negative bacteria, such as sphingomonas. This structure emphasizes the a-branching of the microbial glycolipid as a unique pattern for recognition not only by the conserved NKT cell TCR but also by CD1d. These data also provide a basis for the design of NKT cell ligands with selective T H 1 and T H 2 properties.
METHODS
Reagents and cell lines. The synthesis of a-GalCer and variants has been described 14 . The lipids were resuspended in DMSO at a concentration of 1 mg/ ml and then were diluted to working stock solutions of 0.2 mg/ml with 0.05% Tween 20 in PBS buffer. Trisialoganglioside GT1b was purchased from Matreya. DN32.D3 NKT hybridoma cells and human V a 24 NKT cell lines have been reported 5, 39 . The cells were maintained in RPMI medium (Invitrogen) supplemented with 10% FBS (Gemini Bio-Products), 2 mM L-glutamine (Cambrex) and 20 mM HEPES buffer (Invitrogen).
Protein expression and purification. Recombinant soluble mouse and human CD1d molecules were produced in a fly expression system, as described 17 . Proteins were affinity-purified with nickel-nitrilotriacetic acid-agarose chromatography (Qiagen) followed by anion-exchange chromatography on a MonoQ 10/10 column (GE Healthcare). Purification was monitored by SDS-PAGE. Biotinylation of CD1d was done according to the manufacturer's instructions (Avidity). Protein concentrations were determined with the BCA protein assay kit (Pierce).
Isoelectric focusing electrophoresis. The isoelectric focusing electrophoresis assay to measure lipid loading onto mouse CD1d has been described 17 . Mouse CD1d was loaded with GT1b and purified to obtain a single species. A constant concentration of 2 mM of mouse CD1d-GT1b complexes was used for measuring lipid interactions with a-GalCer and variants. Mouse CD1d-GT1b complexes and lipids were incubated for 1 h at 371 C before loading onto gels. For quantification, gels were scanned and digitized on an Agfa scanner and were quantified with the UN-SCAN-IT software program (Silk Scientific). The amount of a-GalCer or variant bound to mouse CD1d is presented as a percentage of total mouse CD1d in the respective gel lane.
Surface plasmon resonance. A BIACORE 2000 instrument was used to determine interactions between purified CD1-lipid complexes and V a 14 TCR molecules. V a 14 TCR was immobilized by amine-coupling chemistry on a CM5 research-grade sensor chip (Biacore). Successive injections of CD1-lipid complexes were made in filtered and degassed PBS buffer at a flow rate of 20 ml/min at concentrations of 2, 1, 0.5, 0.25 and 0.125 mM. In all experiments, 'empty' CD1d molecules were used as negative control and their results were subtracted from experimental sensorgrams. 'On rates' and 'off rates' were obtained by nonlinear curve fitting of subtracted curves with the 1:1 Langmuir binding model using the BIAevaluation program (version 3.0.2; Biacore).
Thermal denaturation. Thermal denaturation experiments were done by circular dichroism on an AVIV 60DS spectropolarimeter (Aviv Associates) equipped with a thermoelectric cell holder. Circular dichroism spectra were recorded in a cell with a path length of 1.0 mm at a wavelength of 223 nm in temperature increments of 3 1C with a 0.1-second time constant, 10-second averaging time, 3-minute equilibration time and 1-nm bandwidth. Samples contained 8 mM CD1d and 40 mM lipid in a buffer of 10 mM Tris, pH 8.0.
T cell stimulation assays. The CD1d-restricted DN32.D3 NKT cell hybridoma was used in all T cell stimulation assays. For these studies, 96-well plates were coated for 16-24 h with unloaded mouse CD1d molecules at a concentration of 1 mg/well in PBS. Supernatants were collected after 24 h for measurement of IL-2 release with a [ 3 H]thymidine uptake assay using an IL-2-dependent NK cell line 17 . For testing of the loading of a-GalCer lipids onto CD1d, after wells were washed in PBS, lipids were added at various concentrations from the working stock solutions, followed by incubation for 24 h. Wells were washed three times with PBS before the addition of hybridoma cells. For testing of the association and dissociation requirements of a-GalCer lipids, wells were coated with CD1d at a concentration of 1 mg/well and CD1d was loaded with 20 mg/ml of lipid. For dissociation studies, plates were loaded for 24 h and then washed at various times before the addition of cells. For association studies, the respective wells of the plates were washed at various times before the addition of cells.
Decay experiments. CD1d tetramers were prepared as described 46 with stock solutions of a-GalCer, PBS-20 and PBS-25 in DMSO at a concentration of 1 mg/ml for each. Cells derived from human V a 24 NKT cell lines 5 were mixed with a V a 24-negative T cell line as control and were stained with the various tetramers and antibody to human V a 24 (Beckman Coulter). Monoclonal antibody 51 to human CD1d (1 mg/ml; obtained from S. Porcelli, Albert Einstein College of Medicine, Bronx, New York) was added to prevent rebinding of tetramers. At various time points, an aliquot was washed and cells were analyzed on a FACSCalibur (BD Biosciences) with CellQuest software.
In vivo tissue distribution. Glycolipids PBS-25 and a-GalCer were injected intravenously into J a 218-deficient mice at a dose of 1 mg per mouse. Then, 24 h later, splenocytes were collected. B cells, dendritic cells and macrophages were purified using B220, CD11c, CD11b MACS beads (Miltenyi Biotech), respectively. Dendritic cells and macrophages were further purified with antibody to F4/80 (BD Biosciences) and cell sorting to avoid cross-contamination. For overnight stimulation, 2 Â 10 4 cells of each cell type were mixed with 5 Â 10 4 cells of the DN32.D3 NKT cell hybridoma. Stimulation was quantified by measurement of IL-2 secretion.
Protein crystallization. The best crystals were grown overnight at 22 1C, using the sitting-drop vapor-diffusion method, from 1-ml protein drops (7 mg/ml) mixed with 1 ml precipitant (20% PEG 4000 and 0.2 M calcium acetate, pH 7.3).
Structure determination. Crystals were 'flash-cooled' at 100 K in crystallization solution containing 25% glycerol. Diffraction data from a single crystal were collected at beamline 8.2.2 (Advanced Light Source) and were processed to a resolution of 2.2 Å with the DENZO-SCALEPACK suite 47 50 . At a later stage of refinement, N-linked carbohydrates were built at four of the eight total Asn-X-Thr(Ser) motifs (where 'X' is any amino acid except proline and 'Thr(Ser)' is Thr or Ser) in molecules A and B. Starting coordinates for the PBS-25 ligand were obtained with the molecular modeling system INSIGHT II (Accelrys) and then energy was minimized for 100 cycles with the Discover module of INSIGHT II. The ligand libraries for REFMAC 49 were created with the Dundee PRODRG2 Server 51 . Water molecules were assigned throughout the refinement for peaks greater than 3s in an F o -F c map and were retained if they satisfied hydrogen-bonding criteria and returned a 2F o -F c density of more than 1s after refinement. A further drop of 2% in R free was achieved by refining all protein atoms, including the N-linked carbohydrates and the lipid ligands for both molecules in the asymmetric unit, as a total of six independent anisotropic domains with the translation, libration, screw-rotation displacement parameterization in REFMAC. Tight noncrystallographic symmetry restraints were initially applied during the refinement process and the weight for these restraints was lowered gradually toward the final stages of refinement. The CD1d-glycolipid structure had a final R cryst of 24.2% and R free of 29.3%, values that are slightly higher than typically obtained for structures determined at a resolution of 2.2 Å (R free of about 24-28%) 52 . These higher R values, which are generally an indication of the error between the refined structure and the experimental data, are probably due to an approximate noncrystallographic translation between the two CD1 molecules in the asymmetric unit (x ¼ 0.44, y ¼ 0.5, z ¼ 0.03), which results in 'pseudo C-centering' and a large percentage of weak reflections, as noted for an Fab structure 53 . The quality of the model was assessed with the program Molprobity 54 . Buried molecular surface areas and van der Waals contacts were assessed as for the CD1a-sulfatide structure 19 .
Structure presentation. The program PyMOL 55 was used to prepare Figures 3-6 . The programs Molscript 56 , APBS 57 and Raster3D 58 were used to prepare Figure 6 with the coordinates 1CD1 as the 'empty' CD1d structure. Electrostatic surface potentials were calculated with the program APBS 57 and are presented in a color range from red to blue (À30 to +30 kT/e, where k is the Boltzmann constant, T is the absolute temperature and e is the magnitude of the electron charge).
Accession codes. Protein Data Bank: mouse CD1d-PBS-25 complex, 1Z5L. BIND (http://bind.ca): 296746, 296747.
